Accéder au contenu
Merck
  • Quantification of low drug concentration in model formulations with multivariate analysis using surface enhanced Raman chemical imaging.

Quantification of low drug concentration in model formulations with multivariate analysis using surface enhanced Raman chemical imaging.

Journal of pharmaceutical and biomedical analysis (2015-02-01)
Tamás Firkala, Attila Farkas, Balázs Vajna, Zsombor Kristóf Nagy, György Pokol, György Marosi, Imre Miklós Szilágyi
RÉSUMÉ

This paper reports the application of surface enhanced Raman chemical imaging (SER-CI) as a potentially non-destructive quantitative analytical method for the investigation of model pharmaceutical formulations containing the active pharmaceutical ingredient (API) in low concentrations (0.5-2%). The application of chemometric techniques for processing the spectra enables the determination of API distribution in products of different concentrations. In addition, the applied multivariate curve resolution can be proper method to identify unexpected contaminants in illicit drugs. The drastic Raman signal enhancement in the presence of silver nanoparticles provides significantly improved calibration accuracy and, at the same time, radically decreased image acquisition time compared to conventional Raman chemical imaging.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
D-Lactose monohydrate, ≥99% (HPLC), BioUltra
Sigma-Aldrich
D-Lactose monohydrate, ≥98.0% (HPLC)
USP
Lactose monohydrate, United States Pharmacopeia (USP) Reference Standard
Supelco
D-Lactose monohydrate, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-Lactose monohydrate, ACS reagent
Sigma-Aldrich
D-Lactose monohydrate, tested according to Ph. Eur.